Table of contents


Top

Editorial

When less is not more pp791 - 792

doi:10.1038/nm0808-791

Critics of experimentation in nonhuman primates have used a variety of arguments to defend their views. Yet some of those arguments can be used to advocate the use of these animals in biomedical research.


Top

News

Mystery of preterm birth prompts search for better models p793

Coco Ballantyne

doi:10.1038/nm0808-793a


One egg is best p793

Coco Ballantyne

doi:10.1038/nm0808-793b


Researchers see a need for speed in EU trial approvals p794

Daniel Cressey

doi:10.1038/nm0808-794a


Synonym swapping to make vaccines p794

Coco Ballantyne

doi:10.1038/nm0808-794b


Experts urge a more measured look at antioxidants p795

Stu Hutson

doi:10.1038/nm0808-795a


National Cancer Institute helps businesses cross 'the valley of death' p795

Prashant Nair

doi:10.1038/nm0808-795b


A testing approach based on tiny doses still awaits big results p796

Amy Coombs

doi:10.1038/nm0808-796a


Massachusetts pours money into local life sciences research p796

Prashant Nair

doi:10.1038/nm0808-796b


Allergy genes flew the coop, according to evolutionary analysis p797

Coco Ballantyne

doi:10.1038/nm0808-797a


To know or not to know p797

Coco Ballantyne

doi:10.1038/nm0808-797b


News in brief pp798 - 799

doi:10.1038/nm0808-798


Straight talk with...Otmar Kloiber pp800 - 801

doi:10.1038/nm0808-800

Representing some 8 million physicians from over 80 countries across the globe is no easy task, but Otmar Kloiber has handled this responsibility since 2005. As secretary general of the World Medical Association (WMA), Kloiber deals with a wide array of medical topics, ranging from drug-resistant tuberculosis to the ethics of organ transplantation. Founded shortly after World War II, the WMA is a voluntary consortium of national medical associations that fosters physician independence and promotes sound principles of medical care and ethics. Its widely recognized Declaration of Helsinki, an ethical framework designed to protect research subjects, just underwent a round of proposed edits to ensure better protection and greater rewards for research subjects. Kloiber explains the implications of these drafted changes, scheduled for final approval this fall, and the role of the WMA with Coco Ballantyne.


A sporting chance pp802 - 805

Cassandra Willyard

doi:10.1038/nm0808-802

This month, athletes from all over the world will gather in Beijing to compete for the gold. Some will win, some will lose and some will undoubtedly get injured. Cassandra Willyard explores the advances in biomedical research that might help get injured athletes back on the field faster in the future.


Top

Correspondence

Beyond GINA p806

Paul R Billings

doi:10.1038/nm0808-806


Top

Book Review

There will be fat p807

Matthias H Tschöp reviews Rethinking Thin: The New Science of Weight Loss—and the Myths and Realities of Dieting by Gina Kolata

doi:10.1038/nm0808-807


Top

News and Views

M. tuberculosis passes the litmus test pp809 - 810

John D MacMicking

doi:10.1038/nm0808-809

One of the body's key defenders against infection—the activated macrophage—engulfs bacteria and destroys them with an acid cocktail inside lysosomes. Mycobacterium tuberculosis seems to have evolved a strategy to cope with this threat (pages 849–854).

See also: Letter by Vandal et al.


Putting pressure on pre-eclampsia pp810 - 812

Samir M Parikh & S Ananth Karumanchi

doi:10.1038/nm0808-810

Women with pre-eclampsia, a potentially deadly complication of pregnancy, produce agonistic autoantibodies against angiotensin receptor-1, a transmembrane protein that regulates blood pressure. Findings in mice suggest how these antibodies might help trigger the condition (pages 855–862).

See also: Letter by Zhou et al.


Predicting the future for people with lung cancer pp812 - 813

Yang Xie & John D Minna

doi:10.1038/nm0808-812

A large multicenter study shows that lung adenocarcinomas have messenger RNA expression signatures that greatly add to the use of clinical data in predicting an individual's survival (pages 822–827).

See also: Article by Shedden et al.


Top

Community Corner

Capturing cancer stem cells p814

doi:10.1038/nm0808-814


Top

Research Highlights

Research highlights pp816 - 817

doi:10.1038/nm0808-816


Top

Brief Communication

Effective induction of high-titer antibodies by viral vector vaccines pp819 - 821

Simon J Draper, Anne C Moore, Anna L Goodman, Carole A Long, Anthony A Holder, Sarah C Gilbert, Fergal Hill & Adrian V S Hill

doi:10.1038/nm.1850

A novel immunization strategy that involves prime-boost vaccination with a recombinant adenovirus-poxvirus vector can induce strong, antigen-specific antibody responses. Antibodies induced by this viral-vector platform against a Plasmodium antigen are effective in vivo and in vitro.


Top

Articles

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study pp822 - 827

Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Kerby Shedden, Jeremy M G Taylor, Steven A Enkemann, Ming-Sound Tsao, Timothy J Yeatman, William L Gerald, Steven Eschrich, Igor Jurisica, Thomas J Giordano, David E Misek, Andrew C Chang, Chang Qi Zhu, Daniel Strumpf, Samir Hanash, Frances A Shepherd, Keyue Ding, Lesley Seymour, Katsuhiko Naoki, Nathan Pennell, Barbara Weir, Roel Verhaak, Christine Ladd-Acosta, Todd Golub, Michael Gruidl, Anupama Sharma, Janos Szoke, Maureen Zakowski, Valerie Rusch, Mark Kris, Agnes Viale, Noriko Motoi, William Travis, Barbara Conley, Venkatraman E Seshan, Matthew Meyerson, Rork Kuick, Kevin K Dobbin, Tracy Lively, James W Jacobson & David G Beer

doi:10.1038/nm.1790

Studies of gene expression in lung cancer have the potential to affect patient care, but the general applicability of the derived classifiers is unclear. David Beer and his colleagues now analyze more than 400 lung tumors from subjects at six institutions using eight different classifiers and show that the combination of molecular and clinical data best predicts patient survival (pages 812–813).

See also: News and Views by Xie & Minna


Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress pp828 - 836

Irina M Bochkis, Nir E Rubins, Peter White, Emma E Furth, Joshua R Friedman & Klaus H Kaestner

doi:10.1038/nm.1853

The transcription factor Foxa2, which is key for the hepatic control of glucose metabolism, is now shown in this report to also be crucial for proper bile acid homestasis in the liver, as well as to be misregulated in human cholestatic diseases.


Top

Letters

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory pp837 - 842

Ganesh M Shankar, Shaomin Li, Tapan H Mehta, Amaya Garcia-Munoz, Nina E Shepardson, Imelda Smith, Francesca M Brett, Michael A Farrell, Michael J Rowan, Cynthia A Lemere, Ciaran M Regan, Dominic M Walsh, Bernardo L Sabatini & Dennis J Selkoe

doi:10.1038/nm1782

The synaptotoxic Abeta protein aggregates in the brains of individuals with Alzheimer's disease. Dennis Selkoe and his colleagues identify the size of the Abeta aggregate in the brains of individuals with Alzheimer's disease that is responsible for the deficits of learning and memory that characterize the disease.


Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis pp843 - 848

Dan Ehninger, Sangyeul Han, Carrie Shilyansky, Yu Zhou, Weidong Li, David J Kwiatkowski, Vijaya Ramesh & Alcino J Silva

doi:10.1038/nm1788

Tuberous sclerosis is a neurological disorder associated with seizures and cognitive dysfunction. Alcino Silva and his colleagues find that rapamycin, an inhibitor of the mTOR signaling pathway, can ameliorate cognitive deficits in a mouse model of the disease.


A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis pp849 - 854

Omar H Vandal, Lynda M Pierini, Dirk Schnappinger, Carl F Nathan & Sabine Ehrt

doi:10.1038/nm.1795

Acidification of the phagosome is a key mechanism thought to be used by macrophages against Mycobacterium tuberculosis. The authors identify a previously undescribed gene that confers acid resistance to the bacterium and is essential for virulence (pages 809–810).

See also: News and Views by MacMicking


Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice pp855 - 862

Cissy C Zhou, Yujin Zhang, Roxanna A Irani, Hong Zhang, Tiejuan Mi, Edwina J Popek, M John Hicks, Susan M Ramin, Rodney E Kellems & Yang Xia

doi:10.1038/nm.1856

Direct proof that women with pre-eclampsia develop autoantibodies to the AT1 receptor, which explains the hypertension and other symptoms of the disease, is now provided. Additionally, blocking these autoantibodies or treating with losartin, a drug that targets the AT1 receptor, in a new mouse model of this condition helps ameliorate disease outcome (pages 810–812).

See also: News and Views by Parikh & Karumanchi


A tumor necrosis factor-alpha–mediated pathway promoting autosomal dominant polycystic kidney disease pp863 - 868

Xiaogang Li, Brenda S Magenheimer, Sheng Xia, Teri Johnson, Darren P Wallace, James P Calvet & Rong Li

doi:10.1038/nm1783

Polycystic kidney disease can be caused by germline mutations in the gene encoding PC2 followed by a second somatic 'hit' in the normal allele. Li and her colleagues now show that TNF-alpha can also act as a second hit and that disease progression can be blocked by anti–TNF-alpha treatment in an animal model.


Top

Technical Reports

Chip–NMR biosensor for detection and molecular analysis of cells pp869 - 874

Hakho Lee, Eric Sun, Donhee Ham & Ralph Weissleder

doi:10.1038/nm.1711

A major challenge in biomedicine is the rapid and accurate measurement of biomarkers in biological samples. Here, Lee et al. describe a chip-based NMR diagnostic platform that can perform sensitive and selective measurements on small volumes of unprocessed biological samples. This miniaturized biosensing system is high throughput, low cost and portable, and its utility is shown in a number of biomedical applications.


Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2 pp875 - 881

Sergey G Kuznetsov, Pentao Liu & Shyam K Sharan

doi:10.1038/nm.1719

Kuznetsov and his colleagues address a pressing problem in risk assessment for predisposition to breast cancer—whether a particular allele is cancer predisposing or not. Using a two-tiered approach, they have developed a functional assay for the classification of BRCA2 sequence variants of unknown importance. The assay may serve as a model to generate functional assays for other human disease genes.


Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer pp882 - 888

Jeremy B Burton, Mai Johnson, Makoto Sato, Sok Boon S Koh, David J Mulholland, David Stout, Arion F Chatziioannou, Michael E Phelps, Hong Wu & Lily Wu

doi:10.1038/nm.1727

The degree of lymph-node metastasis in prostate cancer is crucial for both staging the disease and planning treatment. Here, Burton and colleagues describe a one-step, non-invasive imaging technology using prostate-specific adenoviral vectors that express imaging reporter genes. This set-up specifically and accurately detects lymph-node metastases in a model of human prostate cancer and eliminates the need for invasive lymphadenectomy required by the current lymphoscintigraphy method.


Top

Corrigendum

Corrigendum: Genomic signatures to guide the use of chemotherapeutics p889

Anil Potti, Holly K Dressman, Andrea Bild, Richard F Riedel, Gina Chan, Robyn Sayer, Janiel Cragun, Hope Cottrill, Michael J Kelley, Rebecca Petersen, David Harpole, Jeffrey Marks, Andrew Berchuck, Geoffrey S Ginsburg, Phillip Febbo, Johnathan Lancaster & Joseph R Nevins

doi:10.1038/nm0808-889


Top

Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

naturejobs

natureproducts


ADVERTISEMENT